Bristol-Myers Squibb Co. (BMY) PT Raised to $65 at Truist Securities, Expects Launches to Drive Momentum
Tweet Send to a Friend
Truist Securities analyst Srikripa Devarakonda raised the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $65.00 (from $62.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
